Add a note about this bill. Your note is for you and will not be shared with anyone.
Because you are a member of panel , your positions on legislation and notes below will be shared with the panel administrators. (More Info)
H.R. 1660 directs the Administrator of the United States Agency for International Development (USAID) to submit to Congress a report—with four annual updates—on the development and use of global health innovations in USAID programs. The report must include information on how USAID is working independently and with partners, donors, and the private sector to develop and bring to scale health products, and how this work is advancing commitments to counter HIV/AIDS, preventable child and maternal deaths, and the spread of infectious diseases.
Last updated Feb 12, 2018. Source: Republican Policy CommitteeThe summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Jan 3, 2019.
Global Health Innovation Act of 2017
This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.
Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.
GovTrack helps everyone learn about and track the activities of the United States Congress. Launched more than 20 years ago, we’re one of the oldest government transparency and accountability websites on the Internet.
This is a project of Civic Impulse, LLC. GovTrack.us is not a government website.